Washington, DC, USA
Innate Pharma's presentations:
- “Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T Cell Lymphomas”, poster presented by Dr Sicard, Sr Director, R&D - Abstract 4733, session Immunology 10, Wednesday April 10, 2013, 8 to 12 am - Hall A-C, Poster Section 5
- "Antitumoral efficacy of therapeutic human anti-KIR antibody in a preclinical xenograft tumor model”, poster presented by Dr Bonnafous, Sr Manager, R&D - Abstract 493, session Immunology 2, Sunday April 7, 2013, 1 to 5 pm - Hall A-C, Poster Section 22
Date